Recordati Industria Chimica e Farmaceutica SpA banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Italy IT
Employees
4 654
IPO date
Jan 1, 1984

Recordati Industria Chimica e Farmaceutica is an Italian pharmaceutical company that develops, manufactures, and sells branded medicines. Its portfolio includes prescription drugs for specialty and rare conditions, along with some consumer healthcare products. It does not mainly sell generic bulk medicine; instead, it focuses on specific treatments where doctors, pharmacies, and hospitals need reliable branded products.

The company makes money by selling these medicines through pharmacies, hospitals, distributors, and healthcare providers in Europe and other markets. It also earns from licensing and other pharmaceutical partnerships when it lets partners use its products or know-how in certain countries. That mix gives it a business based on repeat demand for established treatments rather than one-time product sales.

What makes Recordati different is its focus on smaller therapeutic niches where a drug maker can build deep expertise and a strong position over time. In practice, it acts as a specialist supplier in the healthcare value chain: it develops or acquires medicines, produces them, and then sells them under its own brands to patients and professionals through the healthcare system.

Recordati Industria Chimica e Farmaceutica SpA Investor Relations

Address
Via Matteo Civitali, 1
Milan, Milano
Italy

Business Segments

Business Segments is available only for users with
Unlimited Plan
Unlock Business Segments

Specialty and primary care

This part of Recordati sells prescription medicines for common and specialist conditions, mainly in Europe and other international markets. It includes medicines used in areas such as urology, cough and cold, and other t...

Customers

Doctors, hospitals, pharmacies, and patients who receive prescription medicines for routine and specialist treatment.

Revenue Model

Recordati earns money by selling these branded medicines through distributors, pharmacies, and healthcare channels.

Rare diseases

This part develops and markets medicines for people with uncommon diseases, including treatments that are often used over long periods and may require specialist care.

Customers

Specialist physicians, hospitals, treatment centers, and patients with rare medical conditions.

Revenue Model

Recordati makes money from selling specialized prescription drugs directly or through healthcare distributors and licensed partners.

Management

Dr. Robert Koremans M.D.

CEO & Director

Biography unavailable

Mr. Luigi Felice La Corte

Group CFO & Executive Director

Biography unavailable

Ms. Cathrin Petty

Executive Director

Biography unavailable

Ms. Eugenia Litz

VP & Head of Investor Relations

Biography unavailable

Ms. Bibianne Bon

Group Chief Legal Officer

Biography unavailable

Ms. Laura Conti

Group Communications Director

Biography unavailable

Mr. Gabriele Finzi

Executive VP of Corporate Development, Licensing & Innovation

Biography unavailable

Ms. Alessandra Abate

Group Chief People & Culture Officer

Biography unavailable

Mr. Raffaele Sabia

Chief Medical Officer

Biography unavailable

Mr. Alberto Martinez

Executive Vice President of Specialty & Primary Care Business Unit

Biography unavailable

1 / 10